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Abstract
Introduction: Although most studies report high frequencies of consent to HIV tests, critics argue that clients are subject to
pressure, that acceptors later indicate they could not have refused, and that provider-initiated HIV testing raises serious ethical
issues. We examine the meaning of consent and why clients think they could not have refused.
Methods: Clients in Burkina Faso, Kenya, Malawi and Uganda were asked about consenting to HIV tests, whether they thought
they could have refused and why. Textual responses were analyzed using qualitative and statistical methods.
Results: Among 926 respondents, 77% reported they could not have said no, but in fact, 60% actively consented to test, 24% had
no objection and only 7% tested without consent. There were few significant associations between categories of consent and
their covariates.
Conclusions: Retrospectively asking clients if they could have refused to test for HIV overestimates coercion. Triangulating
qualitative and quantitative data suggests a considerable degree of agency.
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Introduction
One of the most contentious issues in debates around the
scale-up of HIV testing is whether informed consent can be
ensured when testing is routinized [14]. Recent reviews have
shown the trade-offs of different approaches to testing [5,6]
and an analysis of testing policies in sub-Saharan Africa has
highlighted complicated ethical dilemmas regarding consent
and confidentiality when HIV policy is put into practice ‘‘on
the ground’’ [7]. Observers have expressed concern that
routine testing may be perceived as mandatory, and that
some individuals who appear to consent have, in fact, been
subjected to various degrees of coercion [810].
There is a vast literature on informed consent, and it is
mostly focused on two of the three elements that are deemed
to be essential, namely information and competence to make
a choice. The third element, voluntariness, has received less
attention, but there are concerns that participants, especially
in the developing world, frequently believe they are not free
to refuse or withdraw [11,12]. Regarding HIV, an often-cited
study [13] reported that among 56 antenatal clinic attenders
in South Africa who consented to participate in a research
project, 88% later reported feeling pressured. Since then,
the option to refuse has been highlighted, and researchers
have tried to ascertain consent by asking clients retrospec-
tively whether they thought they could have refused to test
for HIV. The evidence from surveys seems to substantiate
concerns about coercion. In Botswana, 93% of 1268 partici-
pants consented to test, but 68% believed they could not
refuse [14]. In rural Kenya, virtually all 900 respondents
accepted to test, but only 20% thought they could decline
[15]. In a provider-initiated testing program in Toronto, 30%
of 299 women said they did not believe they could decline to
test [16]. And in Malawi, the majority of 18 antenatal clinic
attenders perceived there was no option to refuse testing [8].
Such results have been attributed to clients’ dependence on
providers for health services, their fears that their care would
be jeopardized if they refused and, more generally, the power
differential between patients and health professionals.
The discrepancy between explicit acceptance of testing
and perceived option to refuse raises important questions
regarding the optimal way to assess consent and what con-
stitutes unacceptable pressure. Because voluntariness is a
somewhat subjective notion, it cannot be fully captured by
simple indicators, and efforts are needed to elicit individuals’
perceptions and experiences. But large surveys are con-
strained by the use of closed-ended questions, while studies
that listen to clients’ voices tend to be small-scale, with
limited generalizability. The MATCH (Multi-country African
Testing and Counselling for HIV) study represents an effort to
combine quantifiable and textual data about HIV testing on
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a relatively large sample in four African countries. Indicator
measures based on closed-ended questions showed that
the near totality of respondents reported consenting [17].
Additional data about the circumstances of testing were
also collected, based on clients’ responses to open-ended
questions. The availability of transcribed texts on over 900
respondents represents a special opportunity to measure
voluntariness and gain insights into clients’ decisions to test.
The objectives of this analysis are to ascertain the extent
of consent, based on clients’ reports about their experience;
examine the reasons why some respondents thought they
could not have refused; analyze the associations between
consent, reasons and their covariates; and draw the implica-
tions for HIV testing programs and for definitions and mea-
sures of consent.
Methods
The MATCH study was designed to investigate HIV testing
in four countries. A cross-sectional survey of clients was
conducted in 200809 in Burkina Faso, Kenya, Malawi and
Uganda, at health facilities representing prevalent modes of
testing and major providers of testing services. All respon-
dents present at the selected facilities on the days of the
survey, and who agreed to discuss their experience, were
interviewed. Data were collected about respondents’ socio-
demographic characteristics and their experience with HIV
testing, including their descriptions of consenting to test. The
study was cleared by the institutional review board of each
of the four countries, and by the Ethics Review Committee of
the World Health Organization. Details about the selection of
facilities and respondents, response rates, ethical clearance
and data collection have been previously described [17].
We used data from the consent module in the survey,
specifically, responses to the closed-ended question: ‘‘Do
you think you could have said no?’’, and the open-ended
question: ‘‘Why or why not?’’ Textual responses were re-
corded as close to verbatim as possible and transcribed.
This analysis focuses on two outcome variables: the extent
of consent based on clients’ textual responses, and clients’
reasons for thinking they could not refuse. Covariates that
may have influenced outcome variables include age, gender,
education and a wealth index based on assets and household
amenities, previously described [17].
The analysis of textual data was conducted in NVivo 9.2.
[18]. The transcribed texts were repeatedly reviewed to
discern patterns in discourse about consent. Based on the
themes in the texts, a four-way typology of consent was
developed. A thorough review of each of the 926 responses
was conducted by two authors (CMO, CV) in order to classify
respondents into categories of consent, resolve differences
and ensure consistency. The texts regarding reasons for not
being able to refuse were similarly reviewed and recoded,
the themes regrouped and the classification reviewed by two
authors. In addition to software-based recoding and classify-
ing, the texts were read to select illustrative quotes and to
gain insights into decisions regarding testing.
The four-way consent variable and the grouped reasons
why people thought they could not refuse were merged back
into the quantitative data set. Using bivariate (Chi-square)
and multinomial logistic regression analysis, we assessed their
associations with covariates.We modelled the odds that a res-
pondent was in the ‘‘No Objection’’ or ‘‘No Consent’’ category,
respectively, compared with ‘‘Active Consent’’ as the refer-
ence category.We also modelled the likelihood of referring to
health, decisions or providers as reasons why respondents
reported they could not have said no. The multinomial logistic
regression analysis adjusted for country using a fixed effect,
and for clustering of responses at the interview facility. All
statistical analyses were completed in Stata SE 10.1 [19].
Results
A total of 2153 respondents interviewed at health facilities
reported that they tested for HIV in 2007 or later. Respon-
dents who reported testing at their own initiative (1217)
skipped the consent module; other respondents were asked
whether they thought they could have refused and why;
926 respondents provided responses to both questions. They
were mostly young adults (46%, aged 2534); 29% were HIV-
positive; 69% were women; and 42% had secondary educa-
tion. These characteristics are similar to those of the full
sample, except that the full sample had a slightly lower
percentage of women and higher percentage with secondary
education (63% and 48% respectively).
Detailed sample characteristics are presented in Supple-
mentary file S1.
In response to a closed-ended question, 95% of the 926
respondents reported that they agreed to test, 88% said they
were told they had a choice to agree or refuse, 90% said that
no one else was involved in their agreement to test and 93%
thought it was important to be able to refuse to test. These
frequencies suggest prior consideration of HIV testing and
individual choice. Yet when asked if they thought they could
have said no, only 23% said they could have refused. To
better understand this inconsistency, we turn to the textual
data transcribed from respondents’ statements.
Consent based on respondents’ statements
Textual responses provide details, in respondents’ words,
about the circumstances of testing, and represent a sound
basis for assessing voluntariness. Respondents who referred
to proactive decision-making, explicit consent, wanting to
know their status, prior decision, or the importance of
knowing HIV status were classified as having consented.
Those who stated that they did not consent, did not know
they were being tested, or perceived testing to be mandatory
were classified as not having consented.
After reviewing textual responses, it became clear that a
considerable number of respondents did not fit into this
binary classification. Based on themes in the texts, two
additional categories were created. The first, ‘‘No Objection,’’
groups respondents who had neither strong motivations to
test nor clear reasons to refuse: they tested without prior
deliberation, as a result of circumstances, usually in the
course of health care, and while they did not initiate testing,
they conveyed they were not opposed to it. The second
category, ‘‘Ambivalent,’’ groups respondents who expressed
conflicting desires and continuing doubts about the decision
to test: they may have wanted to test but had reservations;
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may have known they had a right to refuse, but felt they did
not want to exercise it; or found themselves in situations
where they could not refuse. A third category, ‘‘Indetermi-
nate,’’ was created for those respondents whose statements
were unclear or too brief to be classified. Criteria used to
classify respondents and illustrative quotes are presented in
Table 1.
Table 2 shows the frequencies of the four-way consent
classification for the 926 respondents. The majority of
respondents (60%) actively consented to test, 24% had no
objection, 4% were ambivalent, 7% did not consent and 5%
were indeterminate. Bivariate associations of the new con-
sent variable with covariates (Supplementary file S2) indicate
that only HIV-positive status was significantly associated with
consent. The statements of the 710 respondents (77%
of the sample) who did not think they could have said no
show that 67% had in fact actively consented, 9% had not con-
sented and 21% had no objection or were ambivalent.
We modelled the associations between categories of con-
sent and covariates, using ‘‘Active Consent’’ as the refer-
ence category, and excluding Indeterminate and Ambivalent
categories, which accounted for few respondents (Table 3).
HIV-positive respondents were significantly less likely to be in
the ‘‘No Consent’’ or ‘‘No Objection’’ categories than in
‘‘Active Consent’’ (OR0.51, CI0.270.99, and OR0.63,
CI0.460.85, respectively), compared with HIV-negative
respondents. Respondents in the second wealth quartile
were significantly less likely to be in the ‘‘No consent’’
category (OR0.47, CI0.270.82) compared to respon-
dents from the poorest wealth quartile. Clients aged 2534
and 45 were significantly less likely (OR0.61, CI
0.490.77, and OR0.56 CI0.330.97 respectively) to
be in the ‘‘No Objection’’ than in the ‘‘Active Consent’’
category compared with younger clients.
Respondents’ reasons
Why 7% respondents tested without consent
Apart from a few respondents who were too sick to give
consent, testing without consent occurred when testing
was presented as mandatory. This happened in the course
of Prevention of Mother-To-Child Transmission (PMTCT),
when pregnant women assumed that HIV testing was part
of antenatal care and that they had no choice, saying
for example: We were told that testing is a must for pregnant
Table 1. Categories of consent to HIV testing
Category Criteria
Illustrative excerpts from
respondents’ statements
1. Actively consented Wanted to test
Made a prior decision
Concerned about health and sees test as important
Favourable to testing
I wanted to know my status
I wanted to confirm my status
I wanted the test; I wanted treatment
Testing with partner
I wanted to get help
To be able to plan for my life
I was ready for it
2. No objection to testing No reasons to refuse testing
Took the opportunity to test when offered
Not overly concerned/somewhat nonchalant about testing
No problem with recommendation to test
No reason to refuse
Testing is part of the treatment
I was referred
It was the opportunity to do it
Provider was friendly
Test is free
I was not worried about testing
I was told that I have the choice
I was not forced, I had the right to say no
3. Ambivalent about
testing
Conflicting desires to test or not
Previously consented, though not sure at time of test
Statement includes both positive and negative points about
testing
Could theoretically refuse but felt they could not
Not quite ready but accepted
Initially agreed; once you decide, you can’t refuse
You can’t refuse those who treat you
I did as I was told
I feared the outcome, was not fully prepared to
know
I don’t know why I accepted, I was not myself
4. Did not consent Did not know was being tested
Was not given a choice
Thought testing was mandatory
Test was mandatory
I had no option to refuse
Forced to test by provider
I did not know I was testing for HIV
5. Indeterminate Contradictory or unclear statement
Insufficient information
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Table 2. Frequency of consent variable, by whether or not respondents thought they could have said no (N926)
Could not have said no Could have said no Total
Consent categories N % N % N %
Active consent 476 67.0 78 36.1 554 59.8
No objection 113 15.9 112 51.9 225 24.3
Ambivalent 34 4.8 2 0.9 36 3.9
No consent 66 9.3 2 0.9 68 7.3
Indeterminate 21 3.0 22 10.2 43 4.6
Total 710 100.0 216 100.0 926 100.0
Percent of total 76.7 23.3 100.0
Table 3. Mutually adjusted effect of age, gender, education, wealth, mode of testing, and HIV status on consent
Odds Ratios, Confidence Intervals, and p-values for the likelihood of being in ‘‘No Objection’’ or ‘‘No Consent’’ categories, compared
to Active Consent (reference category)* (N778)**
No objection No consent
OR 95% CI OR p OR 95% CI OR p
Age group in years
1824$
2534 0.61 0.49 0.77 B0.001 0.79 0.51 1.22 0.282
3544 0.73 0.47 1.14 0.170 1.85 0.48 1.50 0.580
45 0.56 0.33 0.97 0.040 0.92 0.39 2.15 0.840
Gender
Female$
Male 1.52 1.01 2.30 0.095 0.68 0.36 1.29 0.237
Education
No formal education$
Primary 1.25 0.78 2.00 0.345 1.24 0.79 1.95 0.349
Secondary or more 1.26 0.68 2.32 0.466 0.96 0.53 1.75 0.895
Wealth index
Lowest$
Second 1.08 0.81 1.42 0.604 0.47 0.27 0.82 0.008
Third 1.34 0.94 1.90 0.104 0.76 0.46 1.28 0.302
Highest 1.45 0.90 2.35 0.128 0.90 0.49 1.65 0.734
Mode of testing
Integrated$
VCT 0.69 0.34 1.42 0.316 0.49 0.12 1.97 0.316
PMTCT 1.38 0.78 2.43 0.27 1.37 0.64 2.91 0.417
HIV status
HIV negative$
HIV positive 0.63 0.46 0.85 0.002 0.51 0.27 0.99 0.048
Country
Burkina 0.40 0.24 0.66 B0.001 1.33 0.53 3.38 0.544
Kenya 0.45 0.26 0.79 0.005 0.85 0.36 2.03 0.721
Malawi 0.30 0.19 0.45 B0.001 0.77 0.34 1.76 0.534
Uganda 0.40 0.24 0.66 B0.001 1.33 0.53 3.38 0.544
*Results are adjusted for clustering at the interview facility level; **excludes respondents classified as Indeterminate or Ambivalent, and those
respondents missing information on mode of testing or covariates; $reference category.
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women these days*no testing, no assistance from the
doctor; or they said if I don’t get tested I won’t continue
with antenatal clinic (Malawi); or there was no option to
refuse unless you do not attend ANC (Uganda).
Testing was also perceived as a prerequisite to further
medical care among those who were ill or hospitalized, as in
the following:
The nurse told me they test all in the ward. (male,
Kenya)
Provider said the policy [. . .] is for everyone to be
tested. (female, Kenya)
I thought it was compulsory. (female, Malawi)
It is compulsory for anyone who goes to acute.
(male, Uganda)
It was one of the exams that I had to do before my
surgery. (male, Burkina Faso)
Providers insisted they absolutely wanted me to test,
so I was obliged to do it. (female, Burkina Faso)
Why 77% respondents thought they could not have said no
The reasons invoked by respondents who thought they could
not have said no (689, excluding those ‘‘Indeterminate’’) are
shown in Table 4. The main reasons were:
Table 4. Reasons why respondents thought they could not refuse HIV testing, by categories of consent and covariates (N689)*
Reasons why respondents thought they could not say no
Consent category Decided Health Provider Too late
Active 70.0 29.0 1.1 0
No objection 37.7 11.3 50.0 0.9
Ambivalent 0 23.5 47.1 29.4
No consent 0 1.5 98.5 0
Sex
Male 52.3 23.7 22.7 1.3
Female 57.9 22.6 17.2 2.3
Age in years
1825 55.0 17.0 26.0 2.0
2534 53.0 22.6 22.6 1.9
3544 52.1 34.2 12.8 0.9
45 59.2 30.6 10.2 0
Education
None 35.5 43.3 21.1 0
Primary 52.5 25.3 21.3 1.0
Secondary 61.2 15.7 20.4 2.7
Assets quartiles
Lowest 48.8 26.9 23.8 0.6
Second 58.7 23.8 15.9 1.6
Third 51.6 26.1 21.7 0.6
Highest 55.1 18.0 23.4 3.6
Modes of testing
Integrated 57.4 24.7 16.6 1.3
VCT 70.8 22.0 4.9 2.4
PMTCT 47.3 21.8 29.1 1.8
HIV status**
HIV 51.8 33.3 14.4 0.5
HIV 55.4 18.9 23.6 2.2
Country
Burkina 25.0 42.6 26.9 5.6
Kenya 56.9 15.2 26.1 1.7
Malawi 58.6 24.8 16.6 0
Uganda 65.1 20.2 14.0 0.6
Total (N689) 373 161 144 11
Percent 54.1 23.4 20.9 1.6
*Among 710 who thought they could not say no, and excluding 21 respondents classified as indeterminate; **association statistically significant,
pB0.05.
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I had decided to test/knowing your status is important (54%)
Just over half of respondents who thought they could not
have refused said that they had previously made up their
mind and that testing was their choice, with some implying
that the question ‘‘Could you have said no?’’ did not make
sense. This is illustrated in the following:
I am the one who decided to go and test. (male,
Burkina)
If I came here, it is that I really want to test. I don’t
see why I would say no. The nurse simply wants to
help me know my status and that is what I want.
(female, Burkina)
That is the purpose that brought me to the facility.
(female, Uganda)
Some in this group said they could not refuse because
knowing their HIV status was important:
It was important to know my status and that of [my]
unborn child. (female, Kenya)
. . . because I am preparing for the future of my
baby. (female, Malawi)
I felt it was important for us. Furthermore, I wanted
to build the confidence and trust between me and
my boyfriend. (female, Kenya)
Testing is necessary for treatment and health (23%)
Health concerns were invoked by respondents who perceived
testing as necessary to receive care, as in the following:
Testing is a choice if you seek better health, and
therefore refusing would not be good. (female,
Burkina)
I was coughing a lot and I wanted to know my status
[and] what exactly the cough was. (male, Uganda)
I wanted treatment that exactly suits my disease,
which could be only seen after testing. (male,
Uganda)
I wanted to know indeed and start medication early.
(male, Kenya)
I wanted to know if I have the illness or not, and
be able to be treated or protect myself. (female,
Burkina)
Women tested in PMTCT said they could not refuse because
you have to test, because of the child, to protect it, or to take
precautions [for] my baby.
Too late to change my mind (2%)
A small percentage of respondents, mostly in the ‘‘Ambiva-
lent’’ category, felt they had previously agreed and could
not go back on their decision. A Burkina Faso man ex-
plained how, having agreed, one can no longer refuse
[and] must let providers do what they have to do. A Kenyan
man said it was too late for me to change my mind.
A Ugandan woman said she had to follow through, while a
Burkina woman said that because she had already agreed
to go into the counselling session, she felt obliged to stay
and test.
Health providers’ influence (21%)
Respondents who expected providers would care for them
thought they should not refuse testing when offered. Several
in Burkina Faso expressed their respect for health care
providers, asking rhetorically why would you refuse those
who treat you? Similarly, a Malawi woman said she could not
say no because I know they will help me. Another woman in
Burkina Faso explained that it makes little sense to refuse,
because otherwise health care providers would not be able to
treat [you] and care for you, and if you get worse, what
would you do?
The texts describe a range of ways that providers influence
decisions: being helpful and friendly, explaining and counsel-
ling, encouraging and convincing, and applying various
degrees of pressure. For example, a man in Burkina Faso
explained that health care providers told us that they would
help us live a little longer, and how could one refuse? A
Malawi woman said: because of the way I was advised, it was
tough to say no. Some respondents mentioned fear of
disapproval. A Burkina woman said: If you do not test, they
don’t look at you right when you go to weigh the baby.
Stronger provider insistence and excessive pressure were
experienced by some respondents, as illustrated by the
quotes in the section about perceived mandatory testing.
We modelled the reasons given by those who thought they
could not have said no, comparing health and provider
reasons respectively to ‘‘having decided’’ as the reference
category (Supplementary file S3). Invoking provider reasons
was not associated with covariates, except that it was less
likely for those tested through Voluntary Counselling and
Testing (VCT), and more likely for PMTCT. Invoking health
reasons was more likely among HIV-positive respondents and
those aged 35 ; it was less likely among those with
education at or beyond primary compared to those with
no education.
Complex decisions, similar discourse
Respondents’ statements provide insights into the complexity
of the decision process, particularly when apparently contra-
dictory points are juxtaposed in the same statement. Several
respondents who referred to pressure from providers also
noted that testing was for their own good. A Burkina woman
said: if you come to weigh the baby, they tell you to wait at
the door [for testing], and the way it is done it is hard to
refuse. I think it is important since it is designed to take
precautions to protect the baby. Similarly, a Ugandan woman
said: Because it was [for] my own good, but the provider
had also told me I needed the test, so I could not say no.
Even respondents in the ‘‘No Consent’’ category, seemed to
appreciate the logic of mandatory testing. For example, a
woman from Burkina Faso said: If you come to the hospital
and they ask you [to test] it is hard to refuse because they
want [to protect] your health. A Kenyan woman who did not
consent to PMTCT testing said: When you are expecting, you
have to know. And a Kenyan man who had mandatory testing
said: I wanted the employment, plus it was an opportunity for
me to know my status. Thus even those who explicitly did not
consent sometimes acknowledged the benefits of testing,
and expressed acceptance or resignation.
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There is also a degree of similarity among respondents’
statements, regardless of whether or not they thought they
could have said no. Across all countries, and whether or not
they thought they could have refused, active consenters
referred to individual choice, rights and decisions, as illus-
trated in Table 5.
Discussion
Textual analyses show that 7% of 926 respondents had not
consented. Had we taken closed-ended responses to the
question ‘‘Could you have said no?’’ as indicating lack of
consent, as some studies have done, this would have
overestimated the percentage of ‘‘No consent’’ at 77%. The
84% frequency of consent we found here (subtotal of Active
Consent and No Objection in Table 2) is consistent with our
previous finding that 86% of respondents reported a com-
plete consent index [17].
We found that over one quarter of respondents could not
be unambiguously classified into consenting or not consent-
ing (24% had ‘‘No Objection’’ and 4% were ‘‘Ambivalent’’).
This is consistent with a careful qualitative analysis of
consent in Tanzania, where about one third of 25 respon-
dents indicated neither clear consent nor refusal [20]. Thus,
whereas legal or ethical definitions of consent are binary, in
reality, there are gradations to consent.
Very few of the associations between categories of con-
sent and socio-economic covariates were statistically signifi-
cant. This suggests that these categories have relevance
across different countries and social groups, and that the
likelihood of being in a given consent category was not a
function of being in a particular socio-demographic or socio-
economic group. The finding that HIV-positive respondents
were more likely to be in the ‘‘Active Consent’’ category
provides reassurance that they were not at greater risk of
coercion to test; we examined whether there were more
retesters among those HIV-positive, and found that the pro-
portion of retesters was similar among HIV-positive and
HIV-negative respondents (55.6 and 52.3% respectively,
p0.753).
When explaining why they said they could not have
refused, respondents referred to previous decisions, believ-
ing testing was necessary for treatment and health, and the
influence of health providers. Health providers’ influence is
reported across all modes of testing, and particularly among
PMTCT testers. Our results also indicate that among those
tested through PMTCT, the percent who actively consented
was slightly lower, and the percent who expressed ‘‘No
Objection’’ was slightly higher, than among those tested
through other modes. But the difference was not statistically
significant, and PMTCT testers were not less likely to have
consented; and while the statements of women tested
through PMTCT do indicate some pressure, they also show
that women recognized the importance of testing.
In general, respondents expressed agency even while
reporting pressure to test. As argued in a conceptual analysis
of voluntariness [11], pressure and constraints are not
necessarily incompatible with consent. Nevertheless, contin-
ued vigilance is needed to ensure the right to voluntary
consent, particularly in view of the possibility of excessive
pressure from providers, as documented here in a small
proportion of cases.
Our results confirm that offering testing at health facilities
does not appear to jeopardize informed consent [17]. The
high level of consent we found, compared to studies from
earlier years suggests both that services around HIV testing
may have improved, and that their acceptability has in-
creased, such that more clients agree to test [21]. The con-
siderable percentage of respondents in the ‘‘No Objection’’
category (24%) also suggests that many individuals are
undecided and can be encouraged to test voluntarily when
services around testing are friendly, informative and
convenient [22].
A literature review on informed consent recommended
that researchers probe the responses of respondents in
developing countries, who are less likely to refuse, and more
likely to worry about consequences than their counterparts
in higher income settings [12]. The reports of clients in four
countries reveal that perceiving no option to refuse does not
automatically indicate coercion, and may, in fact, reflect a
considerable degree of agency. ‘‘Could you have said no?’’ is
not a good measure of consent, though it is useful to elicit
information about the factors that influence consent.
There are limitations to this study, including the use of
a facility-based sample that was selected in a systematic
rather than random manner, such that respondents are not
necessarily representative of the population as a whole or of
health care facility users. However, since the goal was to
compare measures of consent among those tested at health
care facilities, this approach was deemed to be appropriate.
Table 5. Similarities in the discourse about decisions to test, among those who thought/did not think they could have refused to
test (illustrative quotes from four countries)
Could have refused Could not have refused
Burkina Faso It is a choice. Testing helps people.
It is better to accept. (M)
I was not forced to test, it is my choice. But I could not refuse because it is
free and protects the child if I have the illness. (F)
If I hadn’t wanted to test I wouldn’t have agreed to it. (F)
Kenya It is my right to do so. (F) [. . .] anyone has the right to say yes or no. (F)
Malawi I wanted to know my status and the illness
that I had to be treated. (M)
I went voluntarily and wanted to know my status. (M)
Uganda Because I make my own decisions. (F) Because I came on my own and was willing to test. (F)
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The fact that interviews took place at health care facilities
may have led respondents to give more favorable answers to
questions about health care services. We do not, however,
think that such social desirability bias is likely. In a previous
analysis, we compared outcomes among respondents who
tested at facilities where interviews were conducted and
those who reported testing at facilities not included in the
MATCH project. We found that responses among those tested
at MATCH facilities were similar to, or less positive than,
among those who did not test at MATCH facilities. This
suggests that the facility environment did not substantially
influence respondents’ reports on the care they received;
hence, social desirability bias did not have much effect on
responses.
Other possible limitations are inherent to qualitative
research. When participants are asked to give responses to
open-ended questions in their own words, the length and
depth of textual responses cannot be standardized, and
judgement has to be exercised in recoding. However, such
texts are valuable precisely because they represent sponta-
neous expressions of respondents’ views. In addition, we
went to great lengths to consistently recode the texts and
standardize the way in which decisions were made about
how to categorize responses, such that the possibility of
misclassification is negligible. Moreover, unlike much quali-
tative research, which tends to be small-scale, this study
elicited textual responses from over 900 respondents. This
provided the opportunity to bring together quantifiable data
and texts, and to integrate statistical and textual analyses.We
believe our effort to combine quantitative rigor and sensi-
tivity to clients’ views lends credence to the results.
Our results underscore the importance of carefully defin-
ing and measuring the three components of informed
consent [11]. Information and competence to choose can
be operationalized as binary indicators and assessed through
closed-ended questions, as was done in our previous analysis
[17], but voluntariness is better measured through qualita-
tive methods that elicit respondents’ perceptions of consent
as a process. The findings have implications for how consent
is conceptualized and measured in diverse settings [11,12],
and, more generally, for international bioethics research on
voluntariness [23,24].
Conclusions
Textual analyses indicate that 7% of respondents tested
without consent, about one quarter expressed no objection
to testing, and the majority (60%) actively consented. This is
in contrast to the high percentage (77%) who thought they
could not refuse. Retrospectively asking clients if they could
have refused HIV tests would overestimate coercion. Many
individuals are undecided, and, hence, improving the friend-
liness and quality of services can encourage them to test.
Clients described the influence of various factors, including
pressure from providers, but their statements nevertheless
indicate voluntariness, thus lending support to efforts to
scale-up testing at health facilities.
The analysis also shows that ‘‘Could you have said no?’’
does not measure consent, but can be used to elicit
information about reasons for agreeing to test. Triangulating
qualitative and quantitative data provides insights into
clients’ views and a more accurate measure of consent.
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